Simtra BioPharma Solutions Invests $14M to Expand ADC Manufacturing Capabilities
Simtra BioPharma Solutions announced a $14 million investment to expand clinical-scale conjugation and purification capabilities for antibody-drug conjugates at its Germany facility.
© Copyright 2025. All Rights Reserved by MedPath